Published in Cell Prolif on August 01, 2006
Activation of GPR30 inhibits the growth of prostate cancer cells through sustained activation of Erk1/2, c-jun/c-fos-dependent upregulation of p21, and induction of G(2) cell-cycle arrest. Cell Death Differ (2010) 1.34
Intercellular propagation of extracellular signal-regulated kinase activation revealed by in vivo imaging of mouse skin. Elife (2015) 0.97
MAPK pathway activation delays G2/M progression by destabilizing Cdc25B. J Biol Chem (2009) 0.92
The activation of G protein-coupled receptor 30 (GPR30) inhibits proliferation of estrogen receptor-negative breast cancer cells in vitro and in vivo. Cell Death Dis (2014) 0.88
Mutated in colorectal cancer (MCC) is a novel oncogene in B lymphocytes. J Hematol Oncol (2014) 0.88
MAP kinase meets mitosis: a role for Raf Kinase Inhibitory Protein in spindle checkpoint regulation. Cell Div (2007) 0.86
Phosphorylated extracellular signal-regulated protein kinases 1 and 2 phosphorylate Sp1 on serine 59 and regulate cellular senescence via transcription of p21Sdi1/Cip1/Waf1. J Biol Chem (2009) 0.86
Cytosolic accumulation of gammaH2AX is associated with tropomyosin-related kinase A-induced cell death in U2OS cells. Exp Mol Med (2008) 0.83
Mid-gestation ovine cardiomyocytes are vulnerable to mitotic suppression by thyroid hormone. Reprod Sci (2012) 0.80
ERK is a novel regulatory kinase for poly(A) polymerase. Nucleic Acids Res (2007) 0.79
Transcript and protein profiling identifies signaling, growth arrest, apoptosis, and NF-κB survival signatures following GNRH receptor activation. Endocr Relat Cancer (2013) 0.79
Intercellular redistribution of cAMP underlies selective suppression of cancer cell growth by connexin26. PLoS One (2013) 0.78
Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev (2001) 14.02
Regulation of the G2/M transition by p53. Oncogene (2001) 7.02
Signal transduction through MAP kinase cascades. Adv Cancer Res (1998) 5.65
Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling. Genes Dev (1998) 5.60
The p21(Cip1) and p27(Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts. EMBO J (1999) 5.44
Protein kinase C alpha activates RAF-1 by direct phosphorylation. Nature (1993) 5.23
Senescence of human fibroblasts induced by oncogenic Raf. Genes Dev (1998) 5.14
Lost in transcription: p21 repression, mechanisms, and consequences. Cancer Res (2005) 4.60
Raf-induced proliferation or cell cycle arrest is determined by the level of Raf activity with arrest mediated by p21Cip1. Mol Cell Biol (1997) 4.36
BCL-2 is phosphorylated and inactivated by an ASK1/Jun N-terminal protein kinase pathway normally activated at G(2)/M. Mol Cell Biol (1999) 4.00
Assembly of cyclin D-dependent kinase and titration of p27Kip1 regulated by mitogen-activated protein kinase kinase (MEK1). Proc Natl Acad Sci U S A (1998) 3.85
Effects of p21(Cip1/Waf1) at both the G1/S and the G2/M cell cycle transitions: pRb is a critical determinant in blocking DNA replication and in preventing endoreduplication. Mol Cell Biol (1998) 3.61
Activation of the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway by conventional, novel, and atypical protein kinase C isotypes. Mol Cell Biol (1998) 3.58
New roles for p21 and p27 cell-cycle inhibitors: a function for each cell compartment? Trends Cell Biol (2003) 3.29
Initiation of a G2/M checkpoint after ultraviolet radiation requires p38 kinase. Nature (2001) 3.25
Ras links growth factor signaling to the cell cycle machinery via regulation of cyclin D1 and the Cdk inhibitor p27KIP1. Mol Cell Biol (1997) 2.99
Sustained activation of extracellular-signal-regulated kinase 1 (ERK1) is required for the continued expression of cyclin D1 in G1 phase. Biochem J (1997) 2.97
High-intensity Raf signal causes cell cycle arrest mediated by p21Cip1. Mol Cell Biol (1997) 2.89
Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F. Nature (1997) 2.78
Signaling via mitogen-activated protein kinase kinase (MEK1) is required for Golgi fragmentation during mitosis. Cell (1998) 2.61
Oncogenic ras and p53 cooperate to induce cellular senescence. Mol Cell Biol (2002) 2.61
Ras signalling linked to the cell-cycle machinery by the retinoblastoma protein. Nature (1997) 2.60
Ras transformation results in an elevated level of cyclin D1 and acceleration of G1 progression in NIH 3T3 cells. Mol Cell Biol (1995) 2.47
New insights into the regulation of protein kinase C and novel phorbol ester receptors. FASEB J (1999) 2.39
Active MAP kinase in mitosis: localization at kinetochores and association with the motor protein CENP-E. J Cell Biol (1998) 2.37
Mitogen-activated protein kinase kinase activity is required for the G(2)/M transition of the cell cycle in mammalian fibroblasts. Proc Natl Acad Sci U S A (1999) 2.29
Activation of Raf-1 signaling by protein kinase C through a mechanism involving Raf kinase inhibitory protein. J Biol Chem (2003) 2.24
Activation of the MKK/ERK pathway during somatic cell mitosis: direct interactions of active ERK with kinetochores and regulation of the mitotic 3F3/2 phosphoantigen. J Cell Biol (1998) 2.20
Taxol-induced apoptosis depends on MAP kinase pathways (ERK and p38) and is independent of p53. Oncogene (2001) 1.95
Ras promotes p21(Waf1/Cip1) protein stability via a cyclin D1-imposed block in proteasome-mediated degradation. EMBO J (2003) 1.55
Distinct cell cycle timing requirements for extracellular signal-regulated kinase and phosphoinositide 3-kinase signaling pathways in somatic cell mitosis. Mol Cell Biol (2002) 1.52
Coadministration of UCN-01 with MEK1/2 inhibitors potently induces apoptosis in BCR/ABL+ leukemia cells sensitive and resistant to ST1571. Cancer Biol Ther (2003) 1.52
MKK7 couples stress signalling to G2/M cell-cycle progression and cellular senescence. Nat Cell Biol (2004) 1.51
The MAP kinase pathway is required for entry into mitosis and cell survival. Oncogene (2004) 1.51
Identification of nuclear beta II protein kinase C as a mitotic lamin kinase. J Biol Chem (1994) 1.42
Ras signalling is required for inactivation of the tumour suppressor pRb cell-cycle control protein. Curr Biol (1997) 1.41
Raf-1/MEK/MAPK pathway is necessary for the G2/M transition induced by nocodazole. J Biol Chem (2000) 1.39
Inhibition of JNK reduces G2/M transit independent of p53, leading to endoreduplication, decreased proliferation, and apoptosis in breast cancer cells. Oncogene (2004) 1.36
Rapid activation of G2/M checkpoint after hypertonic stress in renal inner medullary epithelial (IME) cells is protective and requires p38 kinase. Proc Natl Acad Sci U S A (2001) 1.36
Mitogen-activated protein kinase kinase 2 activation is essential for progression through the G2/M checkpoint arrest in cells exposed to ionizing radiation. J Biol Chem (1999) 1.34
MAPK mediates RAS-induced chromosome instability. J Biol Chem (1999) 1.32
Oncogenes, growth factors and phorbol esters regulate Raf-1 through common mechanisms. Oncogene (1998) 1.31
The role of RB in cell cycle control. Prog Cell Cycle Res (1995) 1.31
Signalling pathways involved in multisite phosphorylation of the transcription factor ATF-2. FEBS Lett (2004) 1.28
Synergy between the Mos/mitogen-activated protein kinase pathway and loss of p53 function in transformation and chromosome instability. Mol Cell Biol (1997) 1.28
The p38 mitogen-activated protein kinase pathway links the DNA mismatch repair system to the G2 checkpoint and to resistance to chemotherapeutic DNA-methylating agents. Mol Cell Biol (2003) 1.24
Critical role of both p27KIP1 and p21CIP1/WAF1 in the antiproliferative effect of ZD1839 ('Iressa'), an epidermal growth factor receptor tyrosine kinase inhibitor, in head and neck squamous carcinoma cells. J Cell Physiol (2003) 1.22
RAF1-activated MEK1 is found on the Golgi apparatus in late prophase and is required for Golgi complex fragmentation in mitosis. J Cell Biol (2003) 1.17
Cell cycle arrest and reversion of Ras-induced transformation by a conditionally activated form of mitogen-activated protein kinase kinase kinase 3. Mol Cell Biol (1999) 1.16
Tyrosine-phosphorylated extracellular signal--regulated kinase associates with the Golgi complex during G2/M phase of the cell cycle: evidence for regulation of Golgi structure. J Cell Biol (2001) 1.16
Chromosomal biomarkers of genomic instability relevant to cancer. Drug Discov Today (2002) 1.16
Raf-1 and Bcl-2 induce distinct and common pathways that contribute to breast cancer drug resistance. Clin Cancer Res (2003) 1.15
Protein kinase C isozyme-mediated cell cycle arrest involves induction of p21(waf1/cip1) and p27(kip1) and hypophosphorylation of the retinoblastoma protein in intestinal epithelial cells. J Biol Chem (1997) 1.13
Requirement for phosphatidylinositol-3 kinase activity during progression through S-phase and entry into mitosis. Cell Signal (2003) 1.12
MEK, ERK, and p90RSK are present on mitotic tubulin in Swiss 3T3 cells: a role for the MAP kinase pathway in regulating mitotic exit. Cell Signal (2001) 1.07
Involvement of p21 in the PKC-induced regulation of the G2/M cell cycle transition. FEBS Lett (1999) 1.06
Stimulation of the Raf/MEK/ERK cascade is necessary and sufficient for activation and Thr-160 phosphorylation of a nuclear-targeted CDK2. J Biol Chem (2002) 1.05
Characterization of Raf-1 activation in mitosis. J Biol Chem (1999) 1.04
Mitotic Raf-1 is stimulated independently of Ras and is active in the cytoplasm. J Biol Chem (1998) 0.93
SAPK/JNK regulates cdc2/cyclin B kinase through phosphorylation and inhibition of cdc25c. Cell Signal (2003) 0.92
Inhibitory effect of p21 in MCF-7 cells is overcome by its coordinated stabilization with D-type cyclins. Oncogene (1999) 0.91
Delta MEKK3:ER* activation induces a p38 alpha/beta 2-dependent cell cycle arrest at the G2 checkpoint. Oncogene (2002) 0.91
Raf-1 is activated during mitosis. J Biol Chem (1995) 0.89
Epidermal growth factor inhibits transiently the progression from G2-phase to mitosis: a receptor-mediated phenomenon in various cells. Cancer Res (1990) 0.87
Cell cycle arrest in the G2 phase induced by phorbol ester and diacylglycerol in vascular endothelial cells. Am J Physiol (1996) 0.82
Protein kinase C inhibits the CAK-CDK2 cyclin-dependent kinase cascade and G1/S cell cycle progression in human diploid fibroblasts. Biochim Biophys Acta (1996) 0.81
A proposed common mechanism by which phorbol esters and epidermal growth factor delay the progression from G2 phase to mitosis of HeLa cells through phospholipid metabolites. Cancer Res (1991) 0.81
PKC activity in rat C6 glioma cells: changes associated with cell cycle and simvastatin treatment. Biochem Biophys Res Commun (1994) 0.80
Ras- and mitogen-activated protein kinase kinase-dependent and -independent pathways in p21Cip1/Waf1 induction by fibroblast growth factor-2, platelet-derived growth factor, and transforming growth factor-beta1. Cell Growth Differ (1999) 0.79
Molecular epidemiology of bartonella infections in patients with bacillary angiomatosis-peliosis. N Engl J Med (1997) 2.71
Cross-cascade activation of ERKs and ternary complex factors by Rho family proteins. EMBO J (1997) 2.57
Effects of an immunostimulating agent on acute exacerbations and hospitalizations in patients with chronic obstructive pulmonary disease. The PARI-IS Study Steering Committee and Research Group. Prevention of Acute Respiratory Infection by an Immunostimulant. Am J Respir Crit Care Med (1997) 2.04
Detection of chlamydiosis in a shipment of pet birds, leading to recognition of an outbreak of clinically mild psittacosis in humans. Clin Infect Dis (1998) 1.49
The effect of the doctor-patient relationship on emergency department use among the elderly. Am J Public Health (2000) 1.43
Tyrosine-phosphorylated extracellular signal--regulated kinase associates with the Golgi complex during G2/M phase of the cell cycle: evidence for regulation of Golgi structure. J Cell Biol (2001) 1.16
Two new monoclonal antibodies, Lym-1 and Lym-2, reactive with human B-lymphocytes and derived tumors, with immunodiagnostic and immunotherapeutic potential. Cancer Res (1987) 1.12
Rat hepatocyte proliferation is stimulated by insulin-like peptides in defined medium. Biochem Biophys Res Commun (1982) 1.04
Immunoreactivity of CD45, a protein phosphotyrosine phosphatase, in Alzheimer's disease. Acta Neuropathol (1991) 1.02
A novel method for the detection of necrotic lesions in human cancers. Cancer Res (1988) 1.02
Corticotropin releasing factor receptor-mediated stimulation of adenylate cyclase activity in the rat brain. Brain Res (1986) 1.01
Pathogenesis of early cardiac myocyte damage after severe burns. J Trauma (1999) 0.97
Studies on asymmetric induction associated with the coupling of N-acylamino acids and N-benzyloxycarbonyldipeptides. Int J Pept Protein Res (1991) 0.96
Molecular detection of disseminated tumor cells in the peripheral blood of patients with gastric cancer: evaluation of their prognostic significance. Dis Markers (2006) 0.94
Binding of pyrene to DNA, base sequence specificity and its implication. Nucleic Acids Res (1983) 0.94
Serial experimental and clinical studies on the pathogenesis of multiple organ dysfunction syndrome (MODS) in severe burns. Burns (1998) 0.93
Secure placement of continuous ambulatory peritoneal dialysis catheters under laparoscopic assistance. Am Surg (1999) 0.91
Automated quantitation of hemoglobin-based blood substitutes in whole blood samples. Am J Clin Pathol (2001) 0.91
Actinomycin D binds strongly and dissociates slowly at the dGpdC site with flanking T/T mismatches. Biochemistry (1996) 0.89
Characterization of the high pH wobble structure of the 2-aminopurine.cytosine mismatch by N-15 NMR spectroscopy. Biochem Biophys Res Commun (1989) 0.88
Displacement correction factor for fast-neutron dosimetry in a tissue-equivalent phantom. Med Phys (1976) 0.88
Lithium and inositol: effects on brain water homeostasis in the rat. Psychopharmacology (Berl) (2006) 0.86
Base protonation facilitates B-Z interconversions of poly(dG-dC) X poly(dG-dC). Biochemistry (1984) 0.86
Identification of a C-terminal region that regulates mitogen-activated protein kinase kinase-1 cytoplasmic localization and ERK activation. J Biol Chem (2001) 0.84
Aortic anatomy in children with myelomeningocele and congenital lumbar kyphosis. J Pediatr Orthop (1991) 0.84
Actinomycin D binds strongly to d(CGACGACG) and d(CGTCGTCG). Biophys J (2000) 0.84
Oligonucleotide studies of sequence-specific binding of chromomycin A3 to DNA. Biochemistry (1994) 0.84
Ontogeny of mammalian myocardial beta-adrenergic receptors. Eur J Pharmacol (1979) 0.83
Phorbol ester-induced expression of airway squamous cell differentiation marker, SPRR1B, is regulated by protein kinase Cdelta /Ras/MEKK1/MKK1-dependent/AP-1 signal transduction pathway. J Biol Chem (2000) 0.83
Chronic estrogen treatment reduces angiotensin II receptors in the anterior pituitary. Endocrinology (1983) 0.82
A simple method for studying the solubilization of polycyclic aromatic hydrocarbons in DNA solutions. Anal Biochem (1983) 0.81
Unilateral lumbosacral facet joint dislocation associated with vertical shear sacral fracture. J Orthop Trauma (1991) 0.81
Conformational lability of poly(dG-m5dC):poly(dG-m5dC). Nucleic Acids Res (1986) 0.81
The craniofacial morphologic structures of the adult with Class III malocclusion. Int J Adult Orthodon Orthognath Surg (1995) 0.80
Chronic infusion of angiotensin II into the olfactory bulb elicits an increase in water intake. Brain Res (1983) 0.80
Biomechanical and clinical evaluation of the epitenon-first technique of flexor tendon repair. J Hand Surg Am (1995) 0.79
Anatomical considerations of posterior tibialis tendon entrapment in irreducible lateral subtalar dislocation. Foot Ankle (1992) 0.79
Studies on sensitivity to racemization of activated residues in couplings of N-benzyloxycarbonyldipeptides. Int J Pept Protein Res (1992) 0.79
Mondor's disease in the breast. Kaohsiung J Med Sci (1999) 0.79
A synthesis of N6,N6,N6-trimethyl-L-lysine dioxalate in gram amounts. Biochem Cell Biol (1986) 0.79
DTaP vaccines from north american vaccine (NAVA): composition and critical parameters. Biologicals (1999) 0.78
Expression of β-glucuronidase on the surface of bacteria enhances activation of glucuronide prodrugs. Cancer Gene Ther (2013) 0.78
Multiple hepatic tumors and peliosis hepatis in Fanconi's anemia treated with androgens. Am J Dis Child (1977) 0.78
Self-aggregation of DNA oligomers with XGG trinucleotide repeats: kinetic and atomic force microscopy measurements. Biophys J (1999) 0.77
Temporal variation in nasal and oral breathing in children. Am J Orthod Dentofacial Orthop (1995) 0.77
Effect of intravenous infusion on development of pulmonary oedema after inhalation injury. Burns Incl Therm Inj (1983) 0.76
Primary anaplastic large cell lymphoma of the adrenal gland. Ann Diagn Pathol (2000) 0.76
A comparison of two nitroimidazoles and a dihydroquinoline as radiosensitizers and cytotoxic agents. Int J Radiat Oncol Biol Phys (1979) 0.76
Biochemical markers for assessment of bone metastases in patients with breast cancer. Kaohsiung J Med Sci (1999) 0.76
Fulminant amebiasis: a clinical evaluation. Hepatogastroenterology (1995) 0.76
Hyperoxia inhibits proliferation of cultured rat tracheal smooth muscle cells. Am J Physiol (1994) 0.76
Regular providers for diabetes care. J Fam Pract (1999) 0.75
Antibiotic treatment for threatened abortion during the early first trimester in women with previous spontaneous abortion. Acta Obstet Gynecol Scand (2001) 0.75
[Effect of Tripterygium wilfordii polycoride upon inflammation and TLR4/MyD88 signaling pathway in ulcerative colitis rats model]. Zhonghua Yi Xue Za Zhi (2016) 0.75
Structure-based design of 3-carboxy-substituted 1,2,3,4-tetrahydroquinolines as inhibitors of myeloid cell leukemia-1 (Mcl-1). Org Biomol Chem (2016) 0.75
Reaction mechanisms in peptide synthesis. Part 1. Semiquantitative characteristics of the reactivity of 2-methyl-5(4H)-oxazolone with water and ammonia in the gas phase and weakly polar media. J Comput Aided Mol Des (1991) 0.75
Inclusion complex formation of benzo[a]pyrene metabolites with cyclodextrins. Anal Chem (1988) 0.75
An analysis of suicide. Suicide Life Threat Behav (1985) 0.75
Coping with death in the OR. Todays OR Nurse (1986) 0.75
[The causes of death of early endometrial cancer]. Zhonghua Yi Xue Za Zhi (Taipei) (1990) 0.75
PMS: how does it affect the OR nurse? Todays OR Nurse (1986) 0.75
A bifunctional ligand for Pd(II). Int J Rad Appl Instrum B (1986) 0.75
Immunohistochemical study of transforming growth factor-alpha in human lung cancers. Tumour Biol (1992) 0.75
Gynecologic microsurgery. Todays OR Nurse (1983) 0.75
Inducible versus constitutive PI 227687 soybean resistance to mexican bean beetle,Epilachna varivestis. J Chem Ecol (1987) 0.75
Covalent binding of benzo[a]pyrenediol epoxides to polynucleotides. Biochemistry (1985) 0.75
Studies of the functional significance of angiotensin II receptors in the rat olfactory bulb: evidence for alterations in normal fluid intake. Clin Exp Hypertens A (1982) 0.75
Sequence specific and stereoselective covalent binding of trans-7,8-dihydroxy-anti-9,10-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene to DNA. Prog Clin Biol Res (1985) 0.75
Racemization in peptide synthesis. A laboratory experiment for senior undergraduates. Int J Pept Protein Res (1980) 0.75
[Monitoring of the cardiac function in early experimental treatment of dogs with smoke inhalation injury]. Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi (1985) 0.75
Studies on racemization associated with the use of benzotriazol-1-yl-tris (dimethylamino)phosphonium hexafluorophosphate (BOP). Int J Pept Protein Res (1989) 0.75
Studies on the disproportionation of mixed anhydrides of N-alkoxycarbonylamino acids. Int J Pept Protein Res (1993) 0.75
Haglund's deformity. An electrodynographic approach to analysis. J Am Podiatry Assoc (1984) 0.75
Racemization during aminolysis of activated esters of N-alkoxycarbonylamino acids by amino acid anions in partially aqueous solvents and a tactic to minimize it. Int J Pept Protein Res (1993) 0.75
Binding of Hg(II) to poly(dA): poly(dT) and its component single strands. Biophys Chem (1991) 0.75
New techniques for predicting solar proton fluences for radiation effects applications. IEEE Trans Nucl Sci (1996) 0.75
Energy deposition and ionization fluctuations induced by ions in small sites--an analytical approach. Radiat Res (1994) 0.75
Steroid hormones as feedback regulators of brain angiotensinogen and catecholamines. Chest (1983) 0.75
Covalent binding of (+)- and (-)-trans-7,8-dihydroxy-anti-9,10-epoxy-7,8,9,10-tetrahydrobenzo[a]pyr ene to B and Z DNAs. Biochemistry (1985) 0.75
Blood gas studies in dogs with severe steam inhalation injury. Burns Incl Therm Inj (1987) 0.75
Cell based radioimmunoassays to quantitate the immunoreactivity of TNT monoclonal antibodies directed against intracellular antigens. J Immunoassay (1991) 0.75
Binding of mithramycin to DNA in the presence of second drugs. Biochemistry (1989) 0.75
Caffeine for allergic rhinitis. Lancet (1982) 0.75
Electromyographic evaluation of the inguinal region in patients with hernia of the groin. Surg Gynecol Obstet (1988) 0.75
Nicotinic cholinergic receptors in rat brain identified by [125I]Naja naja siamensis alpha-toxin binding. Brain Res (1977) 0.75
A series of lysyldipeptide derivatives for racemization studies in peptide synthesis. Int J Pept Protein Res (1979) 0.75
The impact of DRGS on the OR. Todays OR Nurse (1987) 0.75
Reductive N,N-dimethylation of amino acid and peptide derivatives using methanol as the carbonyl source. Can J Biochem (1978) 0.75
Role of acid phosphatase measurement in management of prostate cancer. Urology (1981) 0.75
Pelviscopy for ectopic pregnancy: a safer and quicker alternative. Todays OR Nurse (1990) 0.75
Lysyl dipeptide and tripeptide model systems for racemization studies in amino acid and peptide chemistry. Can J Biochem (1979) 0.75
Translaryngeal guided intubation solved a critical airway problem. J Clin Anesth (1988) 0.75
Studies on the use of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline for the synthesis of acylamino acid anilides and p-nitroanilides. Can J Biochem (1978) 0.75
Endoscopic transvesical lower ureterolithotomy. Urology (1986) 0.75
An integrated multielectrode electrophysiology system. J Neurosci Methods (1991) 0.75
Reaction mechanisms in peptide synthesis. Part 2. Tautomerism of the peptide bond. J Comput Aided Mol Des (1991) 0.75
[The changes in cardio-pulmonary function following smoke inhalation injury in goats]. Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi (1988) 0.75
Examination of chiral stability during the preparation of hydrazides and coupling by the azide procedure using a series of model peptides. Int J Pept Protein Res (1982) 0.75
Daunomycin and doxorubicin Lym-1-drug conjugates for the treatment of malignant lymphomas. Cancer Treat Res (1989) 0.75
Sequence specific binding of tetraols of benzo[a]pyrene-diol-epoxide to DNA in neutral and acidic solutions. Carcinogenesis (1984) 0.75